The Roles of Garlic on the Lipid Parameters: A Systematic Review of the Literature

Critical Reviews in Food Science and Nutrition

Volumn 53, Issue 3, 2013, Pages 215-230

  Zeng, Tao ^a   Zhang, Cui Li ^a   Zhao, Xiu Lan ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

cardiovascular disease; garlic; hyperlipidemia; LDL oxidation; lipid

Indexed keywords

ANIMAL STUDIES; BENEFICIAL EFFECTS; CARDIO-VASCULAR DISEASE; CLINICAL TRIAL; GARLIC; HYPERLIPIDEMIA; HYPOLIPIDEMIC EFFECT; IN-VITRO; LDL OXIDATION; LIPID-LOWERING EFFECTS; META-ANALYSIS; ORGANOSULFUR COMPOUNDS; POTENTIAL EFFECTS; SYSTEMATIC REVIEW;

ANIMALS; LIPIDS; SULFUR COMPOUNDS;

EXPERIMENTS; ANIMALS;

ALLIUM SATIVUM; ANIMALIA;

LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT MEDICINAL PRODUCT;

ANIMAL; ANIMAL MODEL; BLOOD; CHEMISTRY; DRUG EFFECT; GARLIC; HUMAN; HYPERLIPIDEMIA; META ANALYSIS (TOPIC); OXIDATION REDUCTION REACTION; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ANIMALS; CHOLESTEROL, LDL; GARLIC; HUMANS; HYPERLIPIDEMIAS; META-ANALYSIS AS TOPIC; MODELS, ANIMAL; OXIDATION-REDUCTION; PHYTOTHERAPY; PLANT PREPARATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84870724671     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2010.523148     Document Type: Article

References (149)

1. Abramovitz, D., Gavri, S., Harats, D., Levkovitz, H., Mirelman, D., Miron, T., Eilat-Adar, S., Rabinkov, A., Wilchek, M., Eldar, M. and Vered, Z. 1999. Allicin-induced decrease in formation of fatty streaks (atherosclerosis) in mice fed a cholesterol-rich diet. Coron Artery Dis., 10: 515-519.
2. Ackermann, R. T., Mulrow, C. D., Ramirez, G., Gardner, C. D., Morbidoni, L. and Lawrence, V. A. 2001. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med., 161: 813-824.
3. Adamu, I., Joseph, P. K. and Augusti, K. T. 1982. Hypolipidemic action of onion and garlic unsaturated oils in sucrose fed rats over a two-month period. Experientia., 38: 899-901.
4. Adler, A. J. and Holub, B. J. 1997. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr., 65: 445-450.
5. Amagase, H. 2006. Clarifying the real bioactive constituents of garlic. J Nutr., 136: 716S-725S.
6. Amagase, H., Petesch, B. L., Matsuura, H., Kasuga, S. and Itakura, Y. 2001. Intake of garlic and its bioactive components. J Nutr., 131: 955S-962S.
7. Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T. and Gonzalez, F. J. 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem., 273: 5678-5684.
8. Apitz-Castro, R., Cabrera, S., Cruz, M. R., Ledezma, E. and Jain, M. K. 1983. Effects of garlic extract and of three pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure. Thromb Res., 32: 155-169.
9. Assaf, S., Hazard, D., Pitel, F., Morisson, M., Alizadeh, M., Gondret, F., Diot, C., Vignal, A., Douaire, M. and Lagarrigue, S. 2003. Cloning of cDNA encoding the nuclear form of chicken sterol response element binding protein-2 (SREBP-2), chromosomal localization, and tissue expression of chicken SREBP-1 and -2 genes. Poult Sci., 82: 54-61.
10. Auer, W., Eiber, A., Hertkorn, E., Hoehfeld, E., Koehrle, U., Lorenz, A., Mader, F., Merx, W., Otto, G. and Schmid-Otto, B. 1990. Hypertension and hyperlipidaemia: Garlic helps in mild cases. Br J Clin Pract Suppl., 69: 3-6.
11. Augusti, K. T., Arathy, S. L., Asha, R., Ramakrishanan, J., Zaira, J., Lekha, V., Smitha, S. and Vijayasree, V. M. 2001. A comparative study on the beneficial effects of garlic (Allium sativum Linn), amLa (Emblica Officinalis Gaertn) and onion (Allium cepa Linn) on the hyperlipidemia induced by butter fat and beef fat in rats. Indian J Exp Biol., 39: 760-766.
12. Bakhsh, R. and Chughtai, M. I. 1984. Influence of garlic on serum cholesterol, serum triglycerides, serum total lipids and serum glucose in human subjects. Nahrung., 28: 159-163.
13. Banerjee, S. K., Mukherjee, P. K. and Maulik, S. K. 2003. Garlic as an antioxidant: The good, the bad and the ugly. Phytother Res., 17: 97-106.
14. Berthold, H. K., Sudhop, T. and von Bergmann, K. 1998. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: A randomized controlled trial. JAMA., 279: 1900-1902.
15. Block, E. 1985. The chemistry of garlic and onions. Sci Am., 252: 114-119.
16. Block, E, Ahmad, S, Jain, M K, Crecely, R W, Apitz-Castro, R and MR., C. 1984. (E, Z)-Ajoene: A potent antithrombic agent from garlic. J Am Chem Soc, 106: 8295-8296.
17. Bordia, A. 1981. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr., 34: 2100-2103.
18. Bordia, A., Arora, S. K., Kothari, L. K., Jain, K. C., Rathore, B. S., Rathore, A. S., Dube, M. K. and Bhu, N. 1975. The protective action of essential oils of onion and garlic in cholesterol-fed rabbits. Atherosclerosis., 22: 103-109.
19. Bordia, A. and Bansal, H. C. 1973. Letter: Essential oil of garlic in prevention of atherosclerosis. Lancet., 2: 1491-1492.
20. Bordia, A., Bansal, H. C., Arora, S. K. and Singh, S. V. 1975. Effect of the essential oils of garlic and onion on alimentary hyperlipemia. Atherosclerosis., 21: 15-19.
21. Borek, C. 2001. Antioxidant health effects of aged garlic extract. J Nutr., 131: 1010S-1015S.
22. Brady, J. F., Ishizaki, H., Fukuto, J. M., Lin, M. C., Fadel, A., Gapac, J. M. and Yang, C. S. 1991. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol., 4: 642-647.
23. Brodnitz, M. H., Pascale, J. V. and van Derslice, L. J. 1971. Flavor components of garlic extract. J Agric Food Chem., 19: 273-275.
24. Brosche, T., Platt, D. and Dorner, H. 1990. The effect of a garlic preparation on the composition of plasma lipoproteins and erythrocyte membranes in geriatric subjects. Br J Clin Pract Suppl., 69: 12-19.
25. Bruce, C., Chouinard, R. A. Jr. and Tall, A. R. 1998. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr., 18: 297-330.
26. Budoff, M. J., Takasu, J., Flores, F. R., Niihara, Y., Lu, B., Lau, B. H., Rosen, R. T. and Amagase, H. 2004. Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: A preliminary study. Prev Med., 39: 985-991.
27. Chang, M. L. and Johnson, M. A. 1980. Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr., 110: 931-936.
28. Chi, M. S. 1982. Effects of garlic products on lipid metabolism in cholesterol-fed rats (41494). Proc Soc Exp Biol Med., 171: 174-178.
29. Chi, M. S., Koh, E. T. and Stewart, T. J. 1982. Effects of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr., 112: 241-248.
30. Das Gupta, A., Das, S. N., Dhundasi, S. A. and Das, K. K. 2008. Effect of garlic (Allium sativum) on heavy metal (nickel II and chromium VI) induced alteration of serum lipid profile in male albino rats. Int J Environ Res Public Health., 5: 147-151.
31. Daugherty, A., Dunn, J. L., Rateri, D. L. and Heinecke, J. W. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest., 94: 437-444.
32. Davenport, D. M. and Wargovich, M. J. 2005. Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food Chem Toxicol., 43: 1753-1762.
33. De, A., Santos, O. S. and Grunwald, J. 1993. Effect of garlic powder tablets on blood lipids and blood pressure: A six month placebo controlled, double blind study. British Journal of Clinical Research., 4: 37-44.
34. Delgoda, R. and Westlake, A. C. 2004. Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicol Rev., 23: 239-249.
35. Dhawan, V. and Jain, S. 2004. Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension. Mol Cell Biochem., 266: 109-115.
36. Dillon, S. A., Burmi, R. S., Lowe, G. M., Billington, D. and Rahman, K. 2003. Antioxidant properties of aged garlic extract: An in vitro study incorporating human low density lipoprotein. Life Sci., 72: 1583-1594.
37. Duda, G., Suliburska, J. and Pupek-Musialik, D. 2008. Effects of short-term garlic supplementation on lipid metabolism and antioxidant status in hypertensive adults. Pharmacol Rep., 60: 163-170.
38. Durak, I., Kavutcu, M., Aytac, B., Avci, A., Devrim, E., Ozbek, H. and Ozturk, H. S. 2004. Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J Nutr Biochem., 15: 373-377.
39. Durak, I., Ozturk, H. S., Olcay, E. and Guven, C. 2002. Effects of garlic extract supplementation on blood lipid and antioxidant parameters and atherosclerotic plaque formation process in cholesterol-fed rabbits. J Herb Pharmacother., 2: 19-32.
40. Egen-Schwind, C., Eckard, R. and Kemper, F. H. 1992. Metabolism of garlic constituents in the isolated perfused rat liver. Planta Med., 58: 301-305.
41. Eilat, S., Oestraicher, Y., Rabinkov, A., Ohad, D., Mirelman, D., Battler, A., Eldar, M. and Vered, Z. 1995. Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic. Coron Artery Dis., 6: 985-990.
42. El-Beshbishy, H. A. 2008. Aqueous garlic extract attenuates hepatitis and oxidative stress induced by galactosamine/lipoploysaccharide in rats. Phytother Res., 22: 1372-1379.
43. Forkert, P. G., Premdas, P. D. and Bowers, R. J. 2000. Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs. Am J Respir Cell Mol Biol., 23: 687-695.
44. Franceschini, G., Maderna, P. and Sirtori, C. R. 1991. Reverse cholesterol transport: physiology and pharmacology. Atherosclerosis., 88: 99-107.
45. Freeman, F. and Kodera, Y. 1995. Garlic chemistry: Stability of S-(2- propenyl)2-propene-1- sulfinothiate (allicin) in blood, solvents, and simulated physiological fluids. J Agric Food Chem., 43: 2332-2338.
46. Gardner, C. D., Chatterjee, L. M. and Carlson, J. J. 2001. The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis., 154: 213-220.
47. Gardner, C. D., Lawson, L. D., Block, E., Chatterjee, L. M., Kiazand, A., Balise, R. R. and Kraemer, H. C. 2007. Effect of raw garlic vs commercial garlic supplements on plasma lipid concentrations in adults with moderate hypercholesterolemia: A randomized clinical trial. Arch Intern Med., 167: 346-353.
48. Gargouri, Y., Moreau, H., Jain, M. K., de Haas, G. H. and Verger, R. 1989. Ajoene prevents fat digestion by human gastric lipase in vitro. Biochim Biophys Acta., 1006: 137-139.
49. Gearing, K. L., Gottlicher, M., Widmark, E., Banner, C. D., Tollet, P., Stromstedt, M., Rafter, J. J., Berge, R. K. and Gustafsson, J. A. 1994. Fatty acid activation of the peroxisome proliferator activated receptor, a member of the nuclear receptor gene superfamily. J Nutr., 124: 1284S-1288S.
50. Gebhardt, R. 1991. Inhibition of cholesterol biosynthesis by a water-soluble garlic extract in primary cultures of rat hepatocytes. Arzneimittelforschung., 41: 800-804.
51. Gebhardt, R. 1993. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids., 28: 613-619.
52. Gebhardt, R. 1995. Amplification of palmitate-induced inhibition of cholesterol biosynthesis in cultured rat hepatocytes by garlic-derived organosulfur compounds. Phytomedicine., 2: 29-34.
53. Gebhardt, R. and Beck, H. 1996. Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures. Lipids., 31: 1269-1276.
54. Gedik, N., Kabasakal, L., Sehirli, O., Ercan, F., Sirvanci, S., Keyer-Uysal, M. and Sener, G. 2005. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats. Life Sci., 76: 2593-2606.
55. Germain, E., Auger, J., Ginies, C., Siess, M. H. and Teyssier, C. 2002. In vivo metabolism of diallyl disulphide in the rat: Identification of two new metabolites. Xenobiotica., 32: 1127-1138.
56. Gorinstein, S., Leontowicz, H., Leontowicz, M., Drzewiecki, J., Najman, K., Katrich, E., Barasch, D., Yamamoto, K. and Trakhtenberg, S. 2006. Raw and boiled garlic enhances plasma antioxidant activity and improves plasma lipid metabolism in cholesterol-fed rats. Life Sci., 78: 655-663.
57. Hardie, D. G. 1992. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim Biophys Acta., 1123: 231-238.
58. Hassan, H. A., El-Agmy, S. M., Gaur, R. L., Fernando, A., Raj, M. H. and Ouhtit, A. 2009. In vivo evidence of hepato- and reno-protective effect of garlic oil against sodium nitrite-induced oxidative stress. Int J Biol Sci., 5: 249-255.
59. Heinle, H. and Betz, E. 1994. Effects of dietary garlic supplementation in a rat model of atherosclerosis. Arzneimittelforschung., 44: 614-617.
60. Helen, A., Rajasree, C. R., Krishnakumar, K., Augusti, K. T. and Vijayammal, P. L. 1999. Antioxidant role of oils isolated from garlic (Allium sativum Linn) and onion (Allium cepa Linn) on nicotine-induced lipid peroxidation. Vet Hum Toxicol, 41: 316-319.
61. Hermann, M., Kapiotis, S., Hofbauer, R., Seelos, C., Held, I. and Gmeiner, B. 1999. Salicylate promotes myeloperoxidase-initiated LDL oxidation: Antagonization by its metabolite gentisic acid. Free Radic Biol Med., 26: 1253-1260.
62. Holzgartner, H., Schmidt, U. and Kuhn, U. 1992. Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate. Arzneimittelforschung., 42: 1473-1477.
63. Iciek, M., Kwiecien, I. and Wlodek, L. 2009. Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen., 50: 247-265.
64. Ide, N. and Lau, B. H. 1997. Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. J Pharm Pharmacol., 49: 908-911.
65. Ide, N., Nelson, A. B. and Lau, B. H. 1997. Aged garlic extract and its constituents inhibit Cu(2+)-induced oxidative modification of low density lipoprotein. Planta Med., 63: 263-264.
66. Ikpeazu, O. V., Agusti, K. T. and Joseph, P. K. 1987. Hypolipidemic effect of garlic extracts mixed with 3% ethanol in rats fed sucrose-high fat diet. Indian J Biochem Biophys., 24: 252-253.
67. Iqbal, M. and Athar, M. 1998. Attenuation of iron-nitrilotriacetate (Fe-NTA)-mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylactic treatment of rats with garlic oil. Food Chem Toxicol., 36: 485-495.
68. Isaacsohn, J. L., Moser, M., Stein, E. A., Dudley, K., Davey, J. A., Liskov, E. and Black, H. R. 1998. Garlic powder and plasma lipids and lipoproteins: A multicenter, randomized, placebo-controlled trial. Arch Intern Med., 158: 1189-1194.
69. Jabbari, A., Argani, H., Ghorbanihaghjo, A. and Mahdavi, R. 2005. Comparison between swallowing and chewing of garlic on levels of serum lipids, cyclosporine, creatinine and lipid peroxidation in renal transplant recipients. Lipids Health Dis., 4: 1-4.
70. Jain, A. K., Vargas, R., Gotzkowsky, S. and McMahon, F. G. 1993. Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med., 94: 632-635.
71. Jin, L. and Baillie, T. A. 1997. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chem Res Toxicol., 10: 318-327. 1-5.
72. Kabasakal, L., Sehirli, O., Cetinel, S., Cikler, E., Gedik, N. and Sener, G. 2005. Protective effect of aqueous garlic extract against renal ischemia/reperfusion injury in rats. J Med Food., 8: 319-326.
73. Kannar, D., Wattanapenpaiboon, N., Savige, G. S. and Wahlqvist, M. L. 2001. Hypocholesterolemic effect of an enteric-coated garlic supplement. J Am Coll Nutr., 20: 225-231.
74. Khoo, Y. S. and Aziz, Z. 2009. Garlic supplementation and serum cholesterol: A meta-analysis. J Clin Pharm Ther., 34: 133-145.
75. Ki, S. H., Choi, J. H., Kim, C. W. and Kim, S. G. 2007. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Chem Biol Interact., 169: 80-90.
76. Kim, S. G., Han, C. Y., Ki, S. H., Kim, Y. W., Noh, K., Lee, D. Y., Kang, B., Ryu, J. H., Jeon, R., Kim, E. H. and Hwang, S. J. 2010. Ajoene, a stable garlic byproduct, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxidants & Redox Signaling., (In Press)
77. Kodera, Y., Suzuki, A., Imada, O., Kasuga, S., Sumioka, I., Kanezawa, A., Taru, N., Fujikawa, M., Nagae, S., Masamoto, K., Maeshige, K. and Ono, K. 2002. Physical, chemical, and biological properties of s-allylcysteine, an amino acid derived from garlic. J Agric Food Chem., 50: 622-632.
78. Kojuri, J., Vosoughi, A. R. and Akrami, M. 2007. Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients. Lipids Health Dis., 6: 1-5.
79. Koseoglu, M., Isleten, F., Atay, A. and Kaplan, Y. C. 2010. Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers. Phytother Res., 24: 374-378.
80. Kuda, T., Iwai, A. and Yano, T. 2004. Effect of red pepper Capsicum annuum var. conoides and garlic Allium sativum on plasma lipid levels and cecal microflora in mice fed beef tallow. Food Chem Toxicol., 42: 1695-1700.
81. Kwon, M. J., Song, Y. S., Choi, M. S., Park, S. J., Jeong, K. S. and Song, Y. O. 2003. Cholesteryl ester transfer protein activity and atherogenic parameters in rabbits supplemented with cholesterol and garlic powder. Life Sci., 72: 2953-2964.
82. Lanzotti, V. 2006. The analysis of onion and garlic. J Chromatogr A., 1112: 3-22.
83. Lau, B. H. and Wang-Cheng, R. 1987. Effect of an odor-modified garlic preparation on blood lipids. Nutrition Research., 7: 139-149.
84. Lau, B. H. 2001. Suppression of LDL oxidation by garlic. J Nutr., 131: 985S-988S.
85. Lawson, L. D., Ransom, D. K. and Hughes, B. G. 1992. Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb Res., 65: 141-156.
86. Lawson, L. D. and Wang, Z. J. 2005. Allicin and allicin-derived garlic compounds increase breath acetone through allyl methyl sulfide: Use in measuring allicin bioavailability. J Agric Food Chem., 53: 1974-1983.
87. Lawson, L. D., Wang, Z. J. and Papadimitriou, D. 2001. Allicin release under simulated gastrointestinal conditions from garlic powder tablets employed in clinical trials on serum cholesterol. Planta Med., 67: 13-18.
88. Lei, Y. P., Chen, H. W., Sheen, L. Y. and Lii, C. K. 2008. Diallyl disulfide and diallyl trisulfide suppress oxidized LDL-induced vascular cell adhesion molecule and E-selectin expression through protein kinase A- and B-dependent signaling pathways. J Nutr., 138: 996-1003.
89. Lei, Y. P., Liu, C. T., Sheen, L. Y., Chen, H. W. and Lii, C. K. 2010. Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein. Mol Nutr Food Res, 54(Suppl 1): S42-S52.
90. Lin, M. C., Wang, E. J., Lee, C., Chin, K. T., Liu, D., Chiu, J. F. and Kung, H. F. 2002. Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine. J Nutr., 132: 1165-1168.
91. Liu, L. and Yeh, Y. Y. 2000. Inhibition of cholesterol biosynthesis by organosulfur compounds derived from garlic. Lipids., 35: 197-203.
92. Luley, C., Lehmann-Leo, W., Moller, B., Martin, T. and Schwartzkopff, W. 1986. Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung., 36: 766-768.
93. Mader, F. H. 1990. Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study. Arzneimittelforschung., 40: 1111-1116.
94. Mathew, B. C., Prasad, N. V. and Prabodh, R. 2004. Cholesterol-lowering effect of organosulphur compounds from garlic: a possible mechanism of action. Kathmandu Univ Med J (KUMJ)., 2: 100-102.
95. McCrindle, B. W., Helden, E. and Conner, W. T. 1998. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med., 152: 1089-1094.
96. Morcos, N. C. 1997. Modulation of lipid profile by fish oil and garlic combination. J Natl Med Assoc., 89: 673-678.
97. Nagae, S., Ushijima, M., Hatono, S., Imai, J., Kasuga, S., Matsuura, H., Itakura, Y. and Higashi, Y. 1994. Pharmacokinetics of the garlic compound S-allylcysteine. Planta Med., 60: 214-217.
98. Neil, H. A., Silagy, C. A., Lancaster, T., Hodgeman, J., Vos, K., Moore, J. W., Jones, L., Cahill, J. and Fowler, G. H. 1996. Garlic powder in the treatment of moderate hyperlipidaemia: A controlled trial and meta-analysis. J R Coll Physicians Lond., 30: 329-334.
99. Nitiyanant, W., Ploybutr, S., Wasuwat, S. and Tandhanand, S. 1987. Effect of the dried powder extract, water soluble of garlic (Allium sativum) on cholesterol, triglyceride and high density lipoprotein in the blood. J Med Assoc Thai, 70: 646-648.
100. Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K. and Shinkai, H. 2000. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature., 406: 203-207.
101. Omurtag, G. Z., Guranlioglu, F. D., Sehirli, O., Arbak, S., Uslu, B., Gedik, N. and Sener, G. 2005. Protective effect of aqueous garlic extract against naphthalene-induced oxidative stress in mice. J Pharm Pharmacol., 57: 623-630.
102. Orekhov, A. N. and Tertov, V. V. 1997. In vitro effect of garlic powder extract on lipid content in normal and atherosclerotic human aortic cells. Lipids., 32: 1055-1060.
103. Ou, C. C., Tsao, S. M., Lin, M. C. and Yin, M. C. 2003. Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic. Lipids., 38: 219-224.
104. Parastoueri, K., Ravanshad, S., Mostaphavi, H. and Setoudehmaram, E. 2006. Effects of garlic tablet on blood sugar, plasma lipids and blood pressure in type 2 diabetic patients with hyperlipidemia. J Medicial Plants., 5: 9-16.
105. Pedraza-Chaverri, J., Maldonado, P. D., Medina-Campos, O. N., Olivares-Corichi, I. M., Granados-Silvestre, M. A., Hernandez-Pando, R. and Ibarra-Rubio, M. E. 2000. Garlic ameliorates gentamicin nephrotoxicity: Relation to antioxidant enzymes. Free Radic Biol Med., 29: 602-611.
106. Peleg, A., Hershcovici, T., Lipa, R., Anbar, R., Redler, M. and Beigel, Y. 2003. Effect of garlic on lipid profile and psychopathologic parameters in people with mild to moderate hypercholesterolemia. Isr Med Assoc J., 5: 637-640.
107. Phelps, S. and Harris, W. S. 1993. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids., 28: 475-477.
108. Plengvidhya, C., Sitprija, S., Chinayon, S., Pasatrat, S. and Tankeyoon, M. 1988. Effects of spray dried garlic preparation on primary hyperlipoproteinemia. J Med Assoc Thai., 71: 248-252.
109. Premdas, P. D., Bowers, R. J. and Forkert, P. G. 2000. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone. J Pharmacol Exp Ther., 293: 1112-1120.
110. Qureshi, A. A., Din, Z. Z., Abuirmeileh, N., Burger, W. C., Ahmad, Y. and Elson, C. E. 1983. Suppression of avian hepatic lipid metabolism by solvent extracts of garlic: Impact on serum lipids. J Nutr., 113: 1746-1755.
111. Rahman, K. 2001. Historical perspective on garlic and cardiovascular disease. J Nutr., 131: 977S-979S.
112. Rahmani, M., Tabari, A. and Niaki, M. 1999. Effect of dried garlic supplementation on blood lipids in mild and moderate hypercholesterolemic patients. Arch Iran Med., 2: 19-23.
113. Rai, S. K., Sharma, M. and Tiwari, M. 2009. Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream target. Life Sci., 85: 211-219.
114. Reinhart, K. M., Talati, R., White, C. M. and Coleman, C. I. 2009. The impact of garlic on lipid parameters: A systematic review and meta-analysis. Nutr Res Rev., 22: 39-48.
115. Roman, R. M., Wendland, A. E. and Polanczyk, C. A. 2008. Myeloperoxidase and coronary arterial disease: From research to clinical practice. Arq Bras Cardiol., 91: e11-e19.
116. Rosen, R. T., Hiserodt, R. D., Fukuda, E. K., Ruiz, R. J., Zhou, Z., Lech, J., Rosen, S. L. and Hartman, T. G. 2001. Determination of allicin, S-allylcysteine and volatile metabolites of garlic in breath, plasma or simulated gastric fluids. J Nutr., 131: 968S-971S.
117. Satitvipawee, P., Rawdaree, P., Indrabhakti, S., Ratanasuwan, T., Getn-gern, P. and Viwatwongkasem, C. 2003. No effect of garlic extract supplement on serum lipid levels in hypercholesterolemic subjects. J Med Assoc Thai., 86: 750-757.
118. Sener, G., Satyroglu, H., Ozer Sehirli, A. and Kacmaz, A. 2003. Protective effect of aqueous garlic extract against oxidative organ damage in a rat model of thermal injury. Life Sci., 73: 81-91.
119. Sener, G., Sehirli, A. O., Ipci, Y., Cetinel, S., Cikler, E. and Gedik, N. 2005. Chronic nicotine toxicity is prevented by aqueous garlic extract. Plant Foods Hum Nutr., 60: 77-86.
120. Sheen, L. Y., Chen, H. W., Kung, Y. L., Liu, C. T. and Lii, C. K. 1999. Effects of garlic oil and its organosulfur compounds on the activities of hepatic drug-metabolizing and antioxidant enzymes in rats fed high- and low-fat diets. Nutrition and Cancer-an International Journal., 35: 160-166.
121. Sheen, L. Y., Wu, C. C., Lii, C. K. and Tsai, S. J. 1999. Metabolites of diallyl disulfide and diallyl sulfide in primary rat hepatocytes. Food Chem Toxicol., 37: 1139-1146.
122. Shoetan, A., Augusti, K. T. and Joseph, P. K. 1984. Hypolipidemic effects of garlic oil in rats fed ethanol and a high lipid diet. Experientia., 40: 261-263.
123. Silagy, C. and Neil, A. 1994. Garlic as a lipid lowering agent: A meta-analysis. J R Coll Physicians Lond., 28: 39-45.
124. Simons, L. A., Balasubramaniam, S., von Konigsmark, M., Parfitt, A., Simons, J. and Peters, W. 1995. On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis., 113: 219-225.
125. Singh, D. K. and Porter, T. D. 2006. Inhibition of sterol 4alpha-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. J Nutr., 136: 759S-764S.
126. Sobenin, I. A., Andrianova, I. V., Demidova, O. N., Gorchakova, T. and Orekhov, A. N. 2008. Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study. J Atheroscler Thromb., 15: 334-338.
127. Sodimu, O., Joseph, P. K. and Augusti, K. T. 1984. Certain biochemical effects of garlic oil on rats maintained on high fat-high cholesterol diet. Experientia., 40: 78-80.
128. Steinberg, D. 1997. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation., 95: 1062-1071.
129. Steiner, M., Khan, A. H., Holbert, D. and Lin, R. I. 1996. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr., 64: 866-870.
130. Steiner, M. and Lin, R. S. 1998. Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract. J Cardiovasc Pharmacol., 31: 904-908.
131. Stevinson, C., Pittler, M. H. and Ernst, E. 2000. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med., 133: 420-429.
132. Sumioka, I., Hayama, M., Shimokawa, Y., Shiraishi, S. and Tokunaga, A. 2006. Lipid-lowering effect of monascus garlic fermented extract (MGFE) in hyperlipidemic subjects. Hiroshima J Med Sci., 55: 59-64.
133. Superko, H. R. and Krauss, R. M. 2000. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol., 35: 321-326.
134. Tanamai, J., Veeramanomai, S. and Indrakosas, N. 2004. The efficacy of cholesterol- lowering action and side effects of garlic enteric coated tablets in man. J Med Assoc Thai., 87: 1156-1161.
135. Thomson, M., Al-Qattan, K. K., Bordia, T. and Ali, M. 2006. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides and triglycerides. Journal of Nutrition., 136: 800s-802s.
136. Turner, B., Molgaard, C. and Marckmann, P. 2004. Effect of garlic (Allium sativum) powder tablets on serum lipids, blood pressure and arterial stiffness in normo-lipidaemic volunteers: a randomised, double-blind, placebo-controlled trial. Br J Nutr., 92: 701-706.
137. van Doorn, M. B., Espirito Santo, S. M., Meijer, P., Kamerling, I. M., Schoemaker, R. C., Dirsch, V., Vollmar, A., Haffner, T., Gebhardt, R., Cohen, A. F., Princen, H. M. and Burggraaf, J. 2006. Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects. Am J Clin Nutr., 84: 1324-1329.
138. Vorberg, G. and Schneider, B. 1990. Therapy with garlic: results of a placebo-controlled, double-blind study. Br J Clin Pract Suppl., 69: 7-11.
139. Warshafsky, S., Kamer, R. S. and Sivak, S. L. 1993. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med., 119: 599-605.
140. Wetterau, J. R., Lin, M. C. and Jamil, H. 1997. Microsomal triglyceride transfer protein. Biochim Biophys Acta., 1345: 136-150.
141. Yang, C. S., Smith, T. J. and Hong, J. Y. 1994. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: Opportunities and limitations. Cancer Res., 54: 1982s-1986s.
142. Yin, L. M. and Shi, Y. G. 2005. Effects of garlic and oat and their compounds on lipid level and hemorheology of hyperlipidemic rats. Acta Academiae Medicinae Militaris Tertiae., 27: 541-544.
143. Zeng, T., Guo, F. F., Zhang, C. L., Zhao, S., Dou, D. D., Gao, X. C. and Xie, K. Q. 2008a. The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice. Chem Biol Interact., 176: 234-242.
144. Zeng, T., Zhang, C. L., Pan, G. B., Zhao, S., Dou, D. D., Xin, X. and Xie, K. Q. 2008b. The protective effects of garlic oil on acute ethanol-induced oxidative stress in the liver of mice. Journal of the Science of Food and Agriculture., 88: 2238-2243.
145. Zeng, T., Zhang, C. L., Song, F. Y., Han, X. Y. and Xie, K. Q. 2009. The modulatory effects of garlic oil on hepatic cytochrome P450s in mice. Hum Exp Toxicol., 28: 777-783.
146. Zeng, T., Zhang, C. L., Zhu, Z. P., Yu, L. H., Zhao, X. L. and Xie, K. Q. 2008c. Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice. Toxicology., 252: 86-91.
147. Zhang, X. H., Lowe, D., Giles, P., Fell, S., Board, A. R., Baughan, J. A., Connock, M. J. and Maslin, D. J. 2001. A randomized trial of the effects of garlic oil upon coronary heart disease risk factors in trained male runners. Blood Coagul Fibrinolysis., 12: 67-74.
148. Zhang, X. H., Lowe, D., Giles, P., Fell, S., Connock, M. J. and Maslin, D. J. 2001. Gender may affect the action of garlic oil on plasma cholesterol and glucose levels of normal subjects. J Nutr., 131: 1471-1478.
149. Zhou, Z., Tan, H. L., Xu, B. X., Ma, Z. C., Gao, Y. and Wang, S. Q. 2005. Microarray analysis of altered gene expression in diallyl trisulfide-treated HepG2 cells. Pharmacol Rep., 57: 818-823.